ACTIVE

Apotheek Weert

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

86,7 k €

+1.0% YoY

Gross margin

180,3 k €

-2.5% YoY

Equity

366,3 k €

+14.6% YoY

Workforce

0,5 ETP

0.0% YoY

What does Apotheek Weert do?

Apotheek Weert is a Private limited company incorporated in 2008. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Oud-Heverlee. It employs on average 0,5 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0898.636.110

Incorporation

06/06/2008

Legal form

Private limited company

Registered office

Leuvensestraat 5
3051 Oud-Heverlee · FlandreSee on map

Contributed capital

20 000,00 €

Latest accounts

31/12/2025

Average workforce

0,5 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008
Income statement
Gross margin	180,3 k €	-2.5%	184,8 k €	+19.4%	154,8 k €	-13.1%	178,2 k €	-0.3%	178,7 k €	+36.0%	131,4 k €	-1.2%	133,1 k €	+14.3%	116,5 k €	+26.3%	92,2 k €	-33.3%	138,2 k €	+49.5%	92,4 k €	-22.3%	119 k €	+17.8%	101 k €	-8.2%	110,1 k €	+20.3%	91,5 k €	+17.4%	78 k €	+11.0%	70,2 k €	+141%	29,2 k €
EBITDA	137,9 k €	+2.2%	134,9 k €	+20.8%	111,7 k €	-8.6%	122,3 k €	+5.3%	116,1 k €	+27.7%	90,9 k €	+9.7%	82,8 k €	+35.7%	61,1 k €	+60.1%	38,2 k €	-64.5%	107,4 k €	+69.9%	63,2 k €	-35.9%	98,7 k €	+21.6%	81,2 k €	-7.7%	88 k €	+27.5%	69 k €	+22.8%	56,2 k €	+18.1%	47,6 k €	+148%	19,2 k €
Operating result	112,5 k €	-4.2%	117,4 k €	+24.6%	94,2 k €	-10.0%	104,7 k €	+5.6%	99,1 k €	+44.7%	68,5 k €	+14.6%	59,8 k €	+214%	19,1 k €	+1239%	1,4 k €	-98.0%	70,3 k €	+168%	26,2 k €	-57.7%	62,1 k €	+79.8%	34,5 k €	-3.2%	35,7 k €	+109%	17,1 k €	+130%	7,4 k €	+1122%	-727,8 €	+12.2%	-829,1 €
Net result	86,7 k €	+1.0%	85,9 k €	+29.2%	66,5 k €	-12.2%	75,7 k €	-1.1%	76,5 k €	+32.8%	57,6 k €	+26.2%	45,6 k €	+215%	14,5 k €	+346%	-5,9 k €	-110%	56,9 k €	+449%	10,4 k €	-77.5%	46,1 k €	+117%	21,2 k €	+47.6%	14,4 k €	+193%	4,9 k €	+167%	-7,3 k €	+15.9%	-8,7 k €	-585%	-1,3 k €
Balance sheet
Equity	366,3 k €	+14.6%	319,6 k €	+7.0%	298,7 k €	+28.6%	232,2 k €	+48.3%	156,5 k €	+63.5%	95,8 k €	+35.6%	70,6 k €	+57.0%	45 k €	+47.4%	30,5 k €	-16.2%	36,4 k €	+23.6%	29,5 k €	+54.3%	19,1 k €	+46.8%	13 k €	+9.2%	11,9 k €	+590%	-2,4 k €	+66.8%	-7,3 k €	-123262%	6 €	-99.9%	8,7 k €
Total assets	734,9 k €	+55.2%	473,6 k €	-13.4%	546,8 k €	+3.0%	531,1 k €	-8.5%	580,7 k €	+21.4%	478,2 k €	+0.6%	475,2 k €	+2.5%	463,6 k €	+17.4%	395 k €	-11.3%	445,3 k €	+7.8%	413,2 k €	-5.7%	438,3 k €	+2.4%	428 k €	-12.0%	486,5 k €	-16.4%	582,1 k €	-0.1%	582,5 k €	-7.0%	626,5 k €	-7.1%	674,5 k €
Cash	258,4 k €	+44.9%	178,3 k €	-31.9%	261,7 k €	+34.8%	194,1 k €	+13.0%	171,8 k €	+322%	40,8 k €	-37.1%	64,8 k €	+89.0%	34,3 k €	-70.6%	116,8 k €	+5.9%	110,3 k €	+35.6%	81,3 k €	+20.1%	67,7 k €	+114%	31,6 k €	-33.5%	47,5 k €	-50.4%	95,9 k €	+55.1%	61,8 k €	-0.8%	62,3 k €	+35.8%	45,9 k €
Debts	366,1 k €	+143%	150,8 k €	-38.1%	243,5 k €	-17.5%	295,2 k €	-30.0%	421,6 k €	+11.0%	379,8 k €	-5.5%	401,9 k €	-3.4%	416,1 k €	+15.0%	362 k €	-10.9%	406,4 k €	+6.6%	381,3 k €	-8.4%	416,2 k €	+0.9%	412,6 k €	-12.5%	471,5 k €	-19.1%	582,5 k €	-1.2%	589,9 k €	-5.8%	626,5 k €	-5.5%	663,3 k €
Other
Workforce	0,5 ETP	0.0%	0,5 ETP	0.0%	0,5 ETP	-28.6%	0,7 ETP	-12.5%	0,8 ETP	+33.3%	0,6 ETP	-57.1%	1,4 ETP	+40.0%	1,0 ETP	0.0%	1,0 ETP	+100%	0,5 ETP	0.0%	0,5 ETP	+25.0%	0,4 ETP	0.0%	0,4 ETP	0.0%	0,4 ETP	0.0%	0,4 ETP	0.0%	0,4 ETP	0.0%	0,4 ETP	+100%	0,2 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 10 ended

Active mandates

Prieels Pharma

Director · since 02 janvier 2025 · until 31 décembre 2025 · 0787.996.326

Represented by Gijs Prieëls

Active

W.D. PARTNERS

Director · since 01 janvier 2025 · until 02 janvier 2025 · 0477.491.408

Represented by Anne Willekens

Active

Ended mandates

Prieels Pharma

Director · since 02 janvier 2025 · 0787.996.326

Represented by Gijs Prieëls

Ended

W.D. PARTNERS

Director · since 01 janvier 2024 · until 02 janvier 2025 · 0477.491.408

Represented by Anne Willekens

Ended

Anne Willekens

Manager

Ended

Anne WILLEKENS

Director

Ended

At this address

Other companies at this address

Company	CBE no.
W.D. PARTNERS● Active	0477.491.408

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	11/06/2026	21/08/2025	11/06/2024	01/06/2023	13/06/2022	19/08/2021
General meeting	30/05/2026	31/05/2025	25/05/2024	27/05/2023	28/05/2022	19/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

18 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	30/05/2026	11/06/2026	Dutch	PDF
Abridged model	31/12/2024	31/05/2025	21/08/2025	Dutch	PDF
Abridged model	31/12/2023	25/05/2024	11/06/2024	Dutch	PDF
Abridged model	31/12/2022	27/05/2023	01/06/2023	Dutch	PDF
Abridged model	31/12/2021	28/05/2022	13/06/2022	Dutch	PDF
Abridged model	31/12/2020	19/06/2021	19/08/2021	Dutch	PDF
Abridged model	31/12/2019	08/09/2020	29/09/2020	Dutch	PDF
Abridged model	31/12/2018	25/05/2019	28/06/2019	Dutch	PDF
Abridged model	31/12/2017	26/05/2018	25/06/2018	Dutch	PDF
Abridged model	31/12/2016	27/05/2017	08/06/2017	Dutch	PDF
Abridged model	31/12/2015	28/05/2016	28/06/2016	Dutch	PDF
Abridged model	31/12/2014	30/05/2015	24/08/2015	Dutch	PDF
Abridged model	31/12/2013	31/05/2014	26/08/2014	Dutch	PDF
Abridged model	31/12/2012	15/06/2013	12/07/2013	Dutch	PDF
Abridged model	31/12/2011	16/06/2012	09/08/2012	Dutch	PDF
Abridged model	31/12/2010	18/06/2011	29/08/2011	Dutch	PDF
Abridged model	31/12/2009	19/06/2010	29/07/2010	Dutch	PDF
Abridged model	31/12/2008	20/06/2009	29/06/2009	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 10 ended

Active mandates

Prieels Pharma

Director · since 02 janvier 2025 · until 31 décembre 2025 · 0787.996.326

Represented by Gijs Prieëls

Active

W.D. PARTNERS

Director · since 01 janvier 2025 · until 02 janvier 2025 · 0477.491.408

Represented by Anne Willekens

Active

Ended mandates

Prieels Pharma

Director · since 02 janvier 2025 · 0787.996.326

Represented by Gijs Prieëls

Ended

W.D. PARTNERS

Director · since 01 janvier 2024 · until 02 janvier 2025 · 0477.491.408

Represented by Anne Willekens

Ended

Anne Willekens

Manager

Ended

Anne WILLEKENS

Director

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates07/01/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Mandates08/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Other27/10/2008
DIVERSEN
PDF
Other27/06/2008
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202586,7 k €↑
2024
Annual accounts 202485,9 k €↑
2024
Name changeApotheek Weert
2023
Annual accounts 202366,5 k €↓
2022
Annual accounts 202275,7 k €↓
2021
Annual accounts 202176,5 k €↑
2021
Name changeApotheek Willekens
2020
Annual accounts 202057,6 k €↑
2019
Annual accounts 201945,6 k €↑
2018
Annual accounts 201814,5 k €↑
2017
Annual accounts 2017-5,9 k €↓
2016
Annual accounts 201656,9 k €↑
2015
Annual accounts 201510,4 k €↓
2014
Annual accounts 201446,1 k €↑
2013
Annual accounts 201321,2 k €↑
2012
Annual accounts 201214,4 k €↑
2011
Annual accounts 20114,9 k €↑
2010
Annual accounts 2010-7,3 k €↑
2009
Annual accounts 2009-8,7 k €↓
2008
Annual accounts 2008-1,3 k €
06/06/2008
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Apotheek Weert

Overview

What does Apotheek Weert do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline